Get started
Author

Mohamed Abdelghani

ORCID: 0000-0002-9888-6588
Observed ORCID: 0000-0002-9888-6588
OpenAlex ID: A5102893125
Connectivity-guided intermittent theta burst versus repetitive transcranial magnetic stimulation for treatment-resistant depression: a randomized controlled trial
2024 · Richard Morriss, Paul M. Briley, et al. · Nature Medicine · 128
PDF
Connectivity guided theta burst transcranial magnetic stimulation versus repetitive transcranial magnetic stimulation for treatment-resistant moderate to severe depression: study protocol for a randomised double-blind controlled trial (BRIGhTMIND)
2020 · Richard Morriss, Lucy Webster, et al. · BMJ Open · 19
PDF
Connectivity-Guided Theta Burst Transcranial Magnetic Stimulation Versus Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Moderate to Severe Depression: Magnetic Resonance Imaging Protocol and SARS-CoV-2–Induced Changes for a Randomized Double-blind Controlled Trial
2021 · Stefan Pszczolkowski, William J Cottam, et al. · JMIR Research Protocols · 15
Early Clinical Experiences of Esketamine Nasal Spray in the UK in Adults with Treatment-Resistant Major Depressive Disorder: Advisory Panel Recommendations
2023 · Allan H Young, Mohamed Abdelghani, et al. · Neuropsychiatric Disease and Treatment · 10
PDF
Knowledge and attitude towards TMS: a brief educational intervention
2020 · Hakan Yonel, Mohamed Abdelghani · Progress in Neurology and Psychiatry · 9
PDF
Acceptability, tolerability and safety of the BRIGhTMIND trial: Connectivity-guided intermittent theta-burst stimulation versus F3- repetitive transcranial magnetic stimulation for treatment-resistant depression
2024 · Lucy Webster, Clement Boutry, et al. · Comprehensive Psychiatry · 5
Works count: 7
Citation count: 187
H-index: 5
I10-index: 4
Year
Topic
Type